Operating Profit Changement Date
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Almirall EUR 38.88M 39.82M 2023-06
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amarin USD -21451000 2.51M 2023-09
Ardelyx USD 7.4M 24.02M 2023-09
Astellas Pharma JPY 5.22B 40.57B 2023-09
AstraZeneca USD 1.95B 502M 2023-09
Bluebird Bio USD -84729000 568K 2023-09
Charles River Laboratories USD 132.92M 18.58M 2023-12
Emergent BioSolutions USD -218000000 69.9M 2023-06
Esperion Therapeutics USD -27533000 9.52M 2023-09
Exact Sciences USD -67841000 74.69M 2023-12
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Incyte USD 187.27M 27.44M 2023-12
Ironwood Pharmaceuticals USD 37.59M 2.43M 2023-12
Lexicon Pharmaceuticals USD -49631000 5.39M 2023-09
Moderna USD 6M 2.02B 2023-12
Myriad Genetics USD -31400000 28.7M 2023-12
Pacira USD 33.17M 15.45M 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Takeda JPY -49342000000 217.91B 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vanda Pharmaceuticals USD -2867000 4.87M 2023-06



Ironwood Pharmaceuticals Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.